Latest posts by Lawrence F Muscarella PhD (see all)
- Are Enzymatic Detergents the Primary Cause of The Inflammatory Eye Reaction Called TASS? A recently published article investigates risk factors for TASS. - March 31, 2018
- Guidance to Prevent Other Flexible Endoscopes From Transmitting Superbug Infections. A new practice is discussed to reduce the risk of multidrug-resistant bacterial infections. - March 26, 2018
- FDA Warns Duodenoscope Manufacturers for Not Completing Ordered Surveillance Studies - March 15, 2018
Lawrence F Muscarella, PhD, is the founder and owner of LFM Healthcare Solutions, LLC, an independent quality improvement and healthcare safety company that advises hospitals, manufacturers and consumers.
Dr. Muscarella is an independent safety expert who advises hospitals, manufacturers, and consumers about medical errors, the safety of medical devices, and how to prevent infections in healthcare facilities, among other topics.
His knowledge and expertise in hospital safety are internationally recognized.
Dr. Muscarella has become a national spokesman and a leading authority promoting practices for the prevention of (among other types of infections and medical devices):
- “superbug” infections, particularly those caused by contaminated duodenoscopes transmitting “CRE” (or, carbapenem-resistant Enterobacteriaceae) to patients during an gastrointestinal endoscopic procedure called “ERCP”; and
- mycobacterial infections linked to contaminated heater-cooler devices used in the operating room to control the patient’s body temperature during cardiothoracic procedures.
Dr. Muscarella’s articles beginning in 2013 discussing the risk of contaminated duodenoscopes infecting patients with deadly “superbug” outbreaks — and his articles beginning in 2014 discussing the association of a contaminated heater-cooler device with a deadly mycobacterial outbreak at a South Carolina hospital — were the first by any U.S. researcher to publicize these risks and emphasize their national (not merely local) implications to public health.
In fact, it was not until almost 2 years after Dr. Muscarella first began publishing on the topic of duodenoscopes infecting patients with superbugs that the FDA, in 2015, first publicly acknowledged this risk.
Similarly, almost 1.5 years after Dr. Muscarella had first written about this risk, the FDA and the CDC, in the fall of 2015, publicly acknowledged for the first time that heater-cooler devices could infect patients with deadly mycobacteria.
In 2013 Lawrence F Muscarella, PhD, founded LFM Healthcare Solutions, LLC — an independent safety and quality improvement company that advises hospitals, manufacturers and consumers.
That same year Dr. Muscarella founded the popular blog — “Discussions in Infection Control” — which is the most replete and independent source of infection-prevention information, featuring more than 170 of Dr. Muscarella’s original articles.
From 1995 to 2013, Dr. Muscarella was the director of research and development, and the chief of infection control, for Custom Ultrasonics, Inc. In 1995, he founded the popular infection control newsletter, “The Q-Net Monthly,” whose publication ended in 2013.
From 1991 through 1994, Dr. Muscarella worked as a project engineer for the ECRI Institute (Plymouth Meeting, PA) evaluating the quality and safety of medical devices and infection control products.
In 1990 Dr. Muscarella received his Ph.D. in bioengineering from the University of Pennsylvania (the School of Engineering and Applied Science; Philadelphia, PA).
Dr. Muscarella also completed a post-doctoral fellowship in diagnostic imaging at the Temple University School of Medicine (Philadelphia, PA).
In 1983 he received a B.S. in physics from Ursinus College (Collegeville, PA), with minors in philosophy and biology.
Dr. Muscarella has been interviewed by more than two dozen news media outlets and shows, including: CNN, NBC’s The Today Show, NBC Nightly News, ABC World News Tonight, the CBS Evening News, Huffington Post Live, Al Jazeera, and Wall Street Journal Live, among others.
Dr. Muscarella’s advice and research have been discussed on the front pages of several U.S. newspapers, including The Wall Street Journal, The Los Angeles Times, The Seattle Times, The Denver Post, Investor’s Business Daily, The San Juan Weekly, and The Allentown Morning Call, among others.
Dr. Muscarella’s advice has also appeared in: USA Today, Bloomberg Business, Newsday, The Philadelphia Inquirer, The Boston Globe, The Pittsburgh Tribune-Review, The York Dispatch, The Winston-Salem Journal, and The Sacramento Bee, among other newspapers.
During the past quarter century, Dr. Muscarella has authored more than 200 articles on the causes and prevention of bacterial outbreaks in hospitals, the design and FDA-regulation of medical devices, risk management, and both the disinfection and sterilization of reusable medical devices.
Many of Dr. Muscarella’s peer-reviewed articles have been published in such medical journals as: The American Journal of Infection Control, Gastrointestinal Endoscopy, Infection Control and Hospital Epidemiology, The Journal of Hospital Infection, Gastroenterology Nursing, Chest, Nature Medicine, Endoscopy, Clinical Gastroenterology and Hepatology, and the World Journal of Clinical Infectious Diseases.
Other articles by Dr. Muscarella were recently published in: World Journal of Gastrointestinal Endoscopy (click here); World Journal of Gastroenterology (click here); Advances in Infectious Diseases (click here); and Open Epidemiology Journal (click here).
In recent years Dr. Muscarella has lectured in Europe, Canada, and at educational conferences hosted throughout the U.S.
Dr. Muscarella’s curriculum vitae (or, “c.v.”) is available on request.
Twitter: Follow Dr. Muscarella: @MuskiePhD
Contact: Lawrence F Muscarella, PhD, President | LFM Healthcare Solutions, LLC | P.O. Box 684, Montgomeryville PA 18936.
Disclaimer: LFM Healthcare Solutions, LLC, is entirely and exclusively responsible for and owns any and all of the content of this blog and website (Discussions in Infection Control), whether the content was posted currently, in the future or in the past. All rights are reserved.